Nuvectis Pharma Inc (NVCT) Stock Price

8.41 ▼ -0.34 (-3.89%)
Open: 8.755 Vol: 0 Day's range: 8.39 - 8.755 Jan 28, 15:58 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
NVCT Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 8.42▼ 8.41▲ 8.44▼ 8.60▼ 8.49▼
MA10 8.43▼ 8.53▼ 8.52▼ 8.51▼ 7.85▲
MA20 8.57▼ 8.52▼ 8.52▼ 8.40▲ 7.01▲
MA50 8.56▼ 8.58▼ 8.51▼ 7.48▲ 7.67▲
MA100 8.53▼ 8.49▼ 8.48▼ 6.82▲ 7.21▲
MA200 8.52▼ 8.32▲ 8.06▲ 7.51▲ 9.09▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.020▼ -0.022▼ -0.020▼ -0.049▼ 0.265▲
RSI 37.585▼ 42.739▼ 44.973▼ 53.967▲ 62.583▲
STOCH 16.378▼ 10.300▼ 26.966     60.857     78.970    
WILL %R -94.521▼ -94.521▼ -94.521▼ -68.687     -26.289    
CCI -56.599     -67.567     -71.803     12.762     84.912    
Latest Filters Detected On NVCT
MA $NVCT Price Crossed Below MA(13) Set Alert
MA $NVCT Price Crossed Below MA(7) Set Alert
CDL $NVCT Engulfing Candlestick Pattern Detected Set Alert
CDL $NVCT Marubozu Candlestick Pattern Detected Set Alert
Nuvectis Pharma Inc News
Nuvectis Pharma's New Phase 1b Trial Targets a Major Lung Cancer Bottleneck (NASDAQ: NVCT)
Wednesday, December 17, 2025 07:06 AM
Resistance remains one of the biggest unsolved problems in modern cancer treatment, and nowhere is that more evident than in lung cancer. AstraZeneca’s Tagrisso has become the gold standard for ...
Nuvectis Pharma Announces the Initiation of the Phase 1b Study of NXP900 in Combination with Osimertinib in Patients with NSCLC
Tuesday, December 16, 2025 11:00 PM
Fort Lee, NJ, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT), a clinical stage biopharmaceutical company focused on the development of innovative precision medicines for the ...
Nuvectis Pharma to Host a Virtual Key Opinion Leader Meeting to Discuss the NXP900 Phase 1b Program in Advanced Solid Tumors, Including the Combination with Osimertinib in NSCLC
Tuesday, November 25, 2025 05:00 AM
Fort Lee, NJ, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NVCT) (NASDAQ: NVCT, the “Company”), a clinical stage biopharmaceutical company focused on the development of innovative ...
NVCT historical stock data
date open high low close volume
28/01/26 8.755 8.755 8.39 8.41 24,836
27/01/26 8.50 8.75 8.38 8.75 53,482
26/01/26 8.55 8.57 8.4401 8.51 23,975
23/01/26 8.7731 8.7731 8.395 8.59 44,438
22/01/26 8.66 8.93 8.285 8.76 51,682
21/01/26 8.22 8.63 8.08 8.58 57,223
20/01/26 8.35 8.48 8.11 8.11 50,751
16/01/26 8.50 8.76 8.44 8.48 56,647
15/01/26 8.25 8.6088 8.20 8.53 37,551
14/01/26 8.25 8.4592 8.05 8.41 39,660
Quote Details
52wk Low:5.55
52wk High:11.52
Vol:0
Avg Vol(3m):1.6M
1Y Chng:+21.01%
1M Chng:+9.93%
Add to Watch List
More Information
Index US Composite
Market Cap. 217.98M